Hims Stock (HIMS) Outlook for 2026: Latest News, Canada Expansion, Buyback and Price Targets as of December 6, 2025
Hims & Hers Health (NYSE: HIMS) is back in the spotlight after a new $250 million buyback, expansion into Canada, and fresh acquisitions in lab testing and blood diagnostics. Here’s a comprehensive look at HIMS stock price, latest news, GLP‑1 risks, and Wall Street forecasts as of December 6, 2025. Hims Stock Today: Price, Valuation and Volatility As of the close on Friday, December 5, 2025, Hims & Hers Health (NYSE: HIMS) finished trading at around $39–39.3 per share, giving the telehealth company a market capitalization of roughly $8.9–9.0 billion. MarketBeat+2CoinCodex+2 Over the last 12 months, HIMS has traded between